Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

Sanofi, MannKind launch diabetes drug Afrezza in US Global healthcare firm Sanofi and California-based biopharmaceutical company MannKind have launched the diabetes treatment Afrezza (insulin human) Inhalation Powder, the only inhaled insulin, in the US. Drug Research > Drug Delivery > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

Bayer's Eylea wins approval in Europe to treat retinal vein occlusion
By PBR Staff Writer
German pharmaceutical firm Bayer HealthCare has received approval from the European Commission for Eylea (aflibercept solution for injection into the eye) to treat patients with visual impairment due to macular edema secondary to retinal vein occlusion (RVO).
News
Amgen reports positive results from Phase III study of AMG 416 with cinacalcet
By PBR Staff Writer
Amgen has reported that the head-to-head Phase III study comparing AMG 416 with cinacalcet has met endpoints in the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) receiving hemodialysis.
News

Drug Discovery & Development

MedImmune, NIST partner to advance drug discovery and manufacturing
By PBR Staff Writer
AstraZeneca's biologics research and development arm MedImmune will partner with US Department of Commerce’s National Institute of Standards and Technology (NIST) to advance development of biological therapies.
News
Takeda, UK’s QMUL partner to develop new therapies for gastrointestinal diseases
By PBR Staff Writer
Japan-based Takeda Pharmaceutical Company (Takeda) has entered into a research collaboration with Queen Mary University of London (QMUL) to define new insights and develop novel therapies for the treatment of gastrointestinal (GI) diseases.
News